Cite
HARVARD Citation
Lodise, T. et al. (2017). Efficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials. Open forum infectious diseases. p. . [Online].